Skip to main content

AVLN

Avalyn Pharma Inc.

Company with tickers: AVLN

CIK
1540171
CUSIP
05348Y105
Shares Outstanding
44,333,095

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Line Item Value
Revenue
Revenue (ASC 606)
Cost of Revenue
Gross Profit
Operating Expenses
Research & Development
Operating Income
Net Income
EPS (Basic)
EPS (Diluted)